Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Time to re-examine physician training

Paul Henderson

    Family Practice Management
    |April 5, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ink detection from surface topography of the Herculaneum papyri.

    Scientific reports·2026
    Same author

    Generative Motion In-Betweening by Diffusion Over Continuous Implicit Representations.

    IEEE transactions on visualization and computer graphics·2026
    Same author

    The incidence and prevalence of paediatric inflammatory bowel disease in Scotland: A nationwide study from 2015 to 2018.

    Journal of pediatric gastroenterology and nutrition·2026
    Same author

    Incidence, Prevalence, Medication Use, and Transplant Rates in Paediatric Autoimmune Hepatitis-A Nationwide Cohort Study.

    Liver international : official journal of the International Association for the Study of the Liver·2026
    Same author

    Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-Week Multicenter Study From the Porto Group of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
    Same author

    Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study.

    Inflammatory bowel diseases·2026